top
Search terms
Results 1 - 5 of 5 - ordered by :
Ehjcvp

Abstract Aims We compared clinical outcomes in patients with AF with and without diabetes in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Justin A. Ezekowitz, Basil S. Lewis, Renato D. Lopes, Daniel M. Wojdyla, John J.V. McMurray, Michael Hanna, Dan Atar, M. ...

Date : 01/04/2015 Item size : 304584 bytes
Ehjcvp

Oral anticoagulation (OAC) is recommended for patients with atrial fibrillation (AF) who are at risk of stroke.1 The CHA2DS2-VASc score, which encompassed a group of common co-morbidities for ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIAL, Jo Jo Hai, Hung-Fat Tse

Date : 01/04/2015 Item size : 156814 bytes
Ehjcvp

DOACsDirect Oral AnticoagulantsNon-vitamin-K oral anticoagulants NOACs Anticoagulation Coagulation testsIntroduction Unlike vitamin K antagonists (VKAs) such as warfarin that reduce hepatic ...

European Heart Journal - Cardiovascular Pharmacotherapy, Reviews, Tomas Salmonson, Jean-Michel Dogné, Heidi Janssen, Juan Garcia Burgos, Paul Blake

Date : 01/01/2017 Item size : 164607 bytes
Ehjcvp

Anti-coagulantAnti-plateletAtrial fibrillationBleeding,HaemorrhageNovel oral anti-coagulantStrokeVitamin K antagonistIntroduction In patients with atrial fibrillation (AF), Vitamin K antagonists ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Ariel Dogliotti, Robert P. Giugliano

Date : 01/01/2015
Ehjcvp

DOACsDirect Oral AnticoagulantsNon-vitamin-K oral anticoagulants NOACs Anticoagulation Coagulation testsIntroduction Unlike vitamin K antagonists (VKAs) such as warfarin that reduce hepatic ...

European Heart Journal - Cardiovascular Pharmacotherapy, Review, Tomas Salmonson, Jean-Michel Dogné, Heidi Janssen, Juan Garcia Burgos, Paul Blake

Date : 07/12/2016